Skip to content

Mozidat Olamide Bello, MD

NPI 1467187872ActiveIndividual· Internal Medicine· Burlington, MA

Internal Medicine (MD) in Burlington, Massachusetts, licensed in MA, with an NPI issued in July 2022. Part D covered 95 prescriptions written in 2024, 87% of them generic. Cvrx, Inc. was the largest of 4 companies reporting payments in 2025, $460.65 in all, mostly food and beverage.

Overview

NPI1467187872
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 19, 2022
Last updated in NPPESJul 19, 2022
Certified by providerJul 19, 2022

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X294749MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)95 · 156 30-day fills
Patients42
Total drug cost$6,760
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$460.65 · 4 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Cvrx, Inc.$151.901
Boston Scientific Corporation$131.361
E.R. Squibb & Sons, L.L.C.$124.991
Abiomed$52.401

What the 2025 payments were for

  • Food and Beverage$460.65 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Burlington

All Internal Medicine providers in Massachusetts →